Your browser doesn't support javascript.
loading
Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence.
McCulloch, Laura; Allan, Stuart M; Emsley, Hedley C; Smith, Craig J; McColl, Barry W.
Affiliation
  • McCulloch L; UK Dementia Research Institute, University of Edinburgh, Edinburgh, EH16 4SB, UK.
  • Allan SM; Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, M13 9PT, UK.
  • Emsley HC; Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YW, UK.
  • Smith CJ; Division of Cardiovascular Sciences, University of Manchester, Manchester, M13 9PT, UK.
  • McColl BW; Greater Manchester Comprehensive Stroke Centre, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK.
F1000Res ; 8: 1039, 2019.
Article in En | MEDLINE | ID: mdl-31700615
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Ischemia / Stroke / Interleukin 1 Receptor Antagonist Protein Type of study: Clinical_trials Limits: Humans Language: En Journal: F1000Res Year: 2019 Document type: Article Affiliation country: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Ischemia / Stroke / Interleukin 1 Receptor Antagonist Protein Type of study: Clinical_trials Limits: Humans Language: En Journal: F1000Res Year: 2019 Document type: Article Affiliation country: Reino Unido